Omnicell Inc (OMCL)
32.63
+0.93
(+2.93%)
USD |
NASDAQ |
May 24, 16:00
32.66
+0.03
(+0.09%)
After-Hours: 20:00
Omnicell Free Cash Flow: 164.56M for March 31, 2024
Free Cash Flow Chart
Historical Free Cash Flow Data
Date | Value |
---|---|
March 31, 2024 | 164.56M |
December 31, 2023 | 126.08M |
September 30, 2023 | 164.96M |
June 30, 2023 | 127.45M |
March 31, 2023 | 47.51M |
December 31, 2022 | 17.04M |
September 30, 2022 | -4.551M |
June 30, 2022 | 17.58M |
March 31, 2022 | 97.85M |
December 31, 2021 | 173.47M |
September 30, 2021 | 194.90M |
June 30, 2021 | 194.19M |
March 31, 2021 | 163.83M |
December 31, 2020 | 131.00M |
September 30, 2020 | 86.16M |
June 30, 2020 | 101.06M |
March 31, 2020 | 85.00M |
December 31, 2019 | 83.34M |
September 30, 2019 | 97.98M |
June 30, 2019 | 58.75M |
March 31, 2019 | 55.08M |
December 31, 2018 | 49.59M |
September 30, 2018 | 8.342M |
June 30, 2018 | -18.58M |
March 31, 2018 | -22.74M |
Date | Value |
---|---|
December 31, 2017 | -5.707M |
September 30, 2017 | 17.58M |
June 30, 2017 | 43.18M |
March 31, 2017 | 28.48M |
December 31, 2016 | 20.74M |
September 30, 2016 | 32.47M |
June 30, 2016 | 21.41M |
March 31, 2016 | 24.79M |
December 31, 2015 | 18.40M |
September 30, 2015 | 16.63M |
June 30, 2015 | 30.25M |
March 31, 2015 | 54.24M |
December 31, 2014 | 42.56M |
September 30, 2014 | 23.81M |
June 30, 2014 | 34.94M |
March 31, 2014 | 31.45M |
December 31, 2013 | 34.81M |
September 30, 2013 | 31.47M |
June 30, 2013 | 18.21M |
March 31, 2013 | 12.09M |
December 31, 2012 | 18.96M |
September 30, 2012 | 28.46M |
June 30, 2012 | 31.80M |
March 31, 2012 | 25.05M |
December 31, 2011 | 18.13M |
Free Cash Flow Range, Past 5 Years
-4.551M
Minimum
Sep 2022
194.90M
Maximum
Sep 2021
106.41M
Average
99.52M
Median
Free Cash Flow Benchmarks
American Shared Hospital Services | -5.155M |
Novo Integrated Sciences Inc | -4.952M |
Astrana Health Inc | 52.44M |
Cryo-Cell International Inc | -0.8021M |
P3 Health Partners Inc | -72.34M |
Free Cash Flow Related Metrics
Cash from Operations (Quarterly) | 49.95M |
Cash from Investing (Quarterly) | -12.34M |
Cash from Financing (Quarterly) | 11.93M |
Free Cash Flow Per Share (Quarterly) | 0.8225 |
Free Cash Flow to Equity (Quarterly) | 36.84M |
Free Cash Flow to Firm (Quarterly) | 37.61M |
Free Cash Flow Yield | 11.07% |